Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Vatter

Showing results (181-190 of 311) with videos related to

Pageof 32
Sort By:
Epilepsia|December 15, 2020
Gene expression analysis in epileptic hippocampi reveals a promoter haplotype conferring reduced aldehyde dehydrogenase 5a1 expression and responsivenessDespina Tsortouktzidis, Herbert Schulz, Motaz Hamed, et al.
Journal of Critical Care|August 3, 2020
Initial inflammatory response is an independent predictor of unfavorable outcome in patients with good-grade aneurysmal subarachnoid hemorrhageErdem Güresir, Christoph Coch, Rolf Fimmers, et al.
Frontiers in Neurology|March 15, 2021
Early Laboratory Predictors for Necessity of Renal Replacement Therapy in Patients With Spontaneous Deep-Seated Intracerebral HemorrhageLorena M Schenk, Matthias Schneider, Christian Bode, et al.
Journal of Clinical Medicine|October 27, 2022
Invasive Diagnostic and Therapeutic Management of Cerebral VasoSpasm after Aneurysmal Subarachnoid Hemorrhage (IMCVS)-A Phase 2 Randomized Controlled TrialHartmut Vatter, Erdem Güresir, Ralph König, et al.
Critical Care Medicine|July 21, 2018
Systemic High-Mobility Group Box-1: A Novel Predictive Biomarker for Cerebral Vasospasm in Aneurysmal Subarachnoid HemorrhageShafqat R Chaudhry, Agi Güresir, Birgit Stoffel-Wagner, et al.
Journal of Neuro-Oncology|September 29, 2020
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality ratesMatthias Schneider, Inja Ilic, Anna-Laura Potthoff, et al.
Brain Sciences|May 16, 2023
Correlation between Blood Type 0 and Risk of Chronic Subdural Hematoma Recurrence: A Single Center Retrospective Cohort StudyMotaz Hamed, Tim Lampmann, Abdallah Salemdawod, et al.
Journal of Neurology|July 2, 2025
Frailty diminishes functional outcome in patients with nonaneurysmal subarachnoid hemorrhage: a dual specialized neurovascular center analysisLarissa Penner, Anna-Laura Potthoff, Tim Lampmann, et al.
Plos One|August 16, 2022
Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsyMalin S Pohlentz, Philipp Müller, Silvia Cases-Cunillera, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2016
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaChristina Schaub, Niklas Schäfer, Frederic Mack, et al.
Pageof 32

Showing results (181-190 of 311) with videos related to

Sort By:
Pageof 32
Epilepsia|December 15, 2020
Gene expression analysis in epileptic hippocampi reveals a promoter haplotype conferring reduced aldehyde dehydrogenase 5a1 expression and responsivenessDespina Tsortouktzidis, Herbert Schulz, Motaz Hamed, et al.
Journal of Critical Care|August 3, 2020
Initial inflammatory response is an independent predictor of unfavorable outcome in patients with good-grade aneurysmal subarachnoid hemorrhageErdem Güresir, Christoph Coch, Rolf Fimmers, et al.
Frontiers in Neurology|March 15, 2021
Early Laboratory Predictors for Necessity of Renal Replacement Therapy in Patients With Spontaneous Deep-Seated Intracerebral HemorrhageLorena M Schenk, Matthias Schneider, Christian Bode, et al.
Journal of Clinical Medicine|October 27, 2022
Invasive Diagnostic and Therapeutic Management of Cerebral VasoSpasm after Aneurysmal Subarachnoid Hemorrhage (IMCVS)-A Phase 2 Randomized Controlled TrialHartmut Vatter, Erdem Güresir, Ralph König, et al.
Critical Care Medicine|July 21, 2018
Systemic High-Mobility Group Box-1: A Novel Predictive Biomarker for Cerebral Vasospasm in Aneurysmal Subarachnoid HemorrhageShafqat R Chaudhry, Agi Güresir, Birgit Stoffel-Wagner, et al.
Journal of Neuro-Oncology|September 29, 2020
Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality ratesMatthias Schneider, Inja Ilic, Anna-Laura Potthoff, et al.
Brain Sciences|May 16, 2023
Correlation between Blood Type 0 and Risk of Chronic Subdural Hematoma Recurrence: A Single Center Retrospective Cohort StudyMotaz Hamed, Tim Lampmann, Abdallah Salemdawod, et al.
Journal of Neurology|July 2, 2025
Frailty diminishes functional outcome in patients with nonaneurysmal subarachnoid hemorrhage: a dual specialized neurovascular center analysisLarissa Penner, Anna-Laura Potthoff, Tim Lampmann, et al.
Plos One|August 16, 2022
Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsyMalin S Pohlentz, Philipp Müller, Silvia Cases-Cunillera, et al.
Journal of Cancer Research and Clinical Oncology|June 20, 2016
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaChristina Schaub, Niklas Schäfer, Frederic Mack, et al.
Pageof 32